Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 353

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 19
Chunk 353
---
 (in addition to, or in lieu of, time-based vesting terms) determined appropriate by the Board of Directors. The specific performance goals, as well as the time period associated with achieving such goals, are approved by the Board and are set forth in the grantee’s grant agreement. To date, each PSU grant has had between three to five performance goals on which vesting is based, each such goal being either a specified Company milestone and or the success of a specific project, with vesting of 20-40% on the achievement of each goal. The tranche of PSUs associated with a given milestone expires 12 months after the target date established for that milestone. As of December 31, 2024,10,371,510PSUs were vested in accordance with their original terms.

As of December 31, 2024, there were142,559,280ordinary shares issuable upon the exercise of outstanding equity instruments under the Plan.

Company employees and directors in Israel are granted options under Section 102 of the Israeli Income Tax Ordinance (the “ Ordinance”), primarily under the “capital gains” track. Israeli non-employees of the Company (consultants and other service providers) are granted options under Section 3(i) of the Ordinance. All non-Israeli employees and non-employees of the Company are granted options as non-qualifies.

As of December 31, 2024, there were53.1million remaining authorized but unissued ordinary shares in the pool reserved for future share-based incentive grants.

  Employee share incentive plan:  

The following table contains additional information concerning equity instruments granted to employees and directors under the existing share incentive plans.

                                        Year ended December 31,                                                                   
                                        Year ended December 31,                                                                   
                                        2022                                                                                      
                                        2022                                                                                      
                                        Number                                                                                    
                                                                                                                                  
                                        of options                                                                                
                                        Number                                                                                    
                                        of options                                                                                
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Outstanding at beginning of year      40,956,214                   0.70      89,871,858       0.44      150,429,825       0.32  
  Granted                               53,696,305                   0.27      64,855,380       0.18      23,190,000        0.20  
  Expired                               ( 1,496,168                  0.98      (